David M. Cognetti
Experienced in Perichondritis

Dr. David M. Cognetti

Otolaryngology
Jefferson Health
Jefferson Otolaryngology (ENT) - Honickman Center
1101 Chestnut Street, Floor 16, 
Philadelphia, PA 
Accepting New Patients
Offers Telehealth
Experienced in Perichondritis
Jefferson Health
Jefferson Otolaryngology (ENT) - Honickman Center
1101 Chestnut Street, Floor 16, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Cognetti is an Otolaryngologist in Philadelphia, Pennsylvania. Dr. Cognetti is rated as an Experienced provider by MediFind in the treatment of Perichondritis. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Duct Stones, Sialadenitis, Laryngectomy, and Gastrostomy. Dr. Cognetti is currently accepting new patients.

His clinical research consists of co-authoring 133 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Pittsburgh School Of Medicine
Residency
Thomas Jefferson University Hospitals
Specialties
Otolaryngology
Licenses
Otolaryngology in PA
Board Certifications
Otolaryngology - Head & Neck Surgery
Otolaryngology
Fellowships
UPMC-University of Pittsburgh Medical Center
Hospital Affiliations
Jefferson Abington Hospital
Thomas Jefferson University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Jefferson Otolaryngology (ENT) - Honickman Center
1101 Chestnut Street, Floor 16, Philadelphia, PA 19107
Call: 215-955-6760

Additional Areas of Focus

Dr. Cognetti has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Laryngeal Cancer
Hyperparathyroidism
Hyperthyroidism

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Pilot Study Using Surgical Resection and Intraoperative Cesium-131 Permanent Interstitial Brachytherapy Implant in Resectable Recurrent Head and Neck Cancer
A Pilot Study Using Surgical Resection and Intraoperative Cesium-131 Permanent Interstitial Brachytherapy Implant in Resectable Recurrent Head and Neck Cancer
Enrollment Status: Completed
Publish Date: September 19, 2025
Intervention Type: Drug, Radiation, Procedure
Study Phase: Early Phase 1
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: June 19, 2025
Intervention Type: Combination product, Biological
Study Drugs: Pembrolizumab, Cemiplimab
Study Phase: Phase 1/Phase 2
A Pilot Trial of a Low-Carbohydrate Normocaloric Diet, in Patients With Head and Neck Carcinoma (HNC) and Its Effect on Stromal-Epithelial Metabolic Uncoupling
A Pilot Trial of a Low-Carbohydrate Normocaloric Diet, in Patients With Head and Neck Carcinoma (HNC) and Its Effect on Stromal-Epithelial Metabolic Uncoupling
Enrollment Status: Completed
Publish Date: May 20, 2025
Intervention Type: Dietary supplement
Study Phase: Not Applicable
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Radiation, Drug
Study Drug: MK-3475
Study Phase: Phase 1
A Pilot Study to Evaluate the Predictive Value of Circulating Tumor DNA for Clinical Outcome in Patients With Advanced Head and Neck and Lung Cancers
A Pilot Study to Evaluate the Predictive Value of Circulating Tumor DNA for Clinical Outcome in Patients With Advanced Head and Neck and Lung Cancers
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Other
Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 28, 2025
Intervention Type: Drug, Radiation, Procedure
Study Drugs: Cisplatin, Carboplatin
Study Phase: Phase 2
A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician's Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma in Patients Who Have Failed or Progressed On or After at Least Two Lines of Therapy, of Which at Least One Line Must Be Systemic Therapy
A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician's Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma in Patients Who Have Failed or Progressed On or After at Least Two Lines of Therapy, of Which at Least One Line Must Be Systemic Therapy
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Drug, Combination product
Study Drugs: ASP-1929, Docetaxel, Cetuximab, Methotrexate, Paclitaxel
Study Phase: Phase 3
A Phase 1 First-in-Human, Drug-dose Escalation Study of RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced Cutaneous Squamous Cell Carcinoma or With Head and Neck Squamous Cell Carcinoma
A Phase 1 First-in-Human, Drug-dose Escalation Study of RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced Cutaneous Squamous Cell Carcinoma or With Head and Neck Squamous Cell Carcinoma
Enrollment Status: Withdrawn
Publish Date: April 19, 2023
Intervention Type: Combination product, Biological
Study Drugs: RM-1995, Pembrolizumab
Study Phase: Phase 1
A Phase 1/2a Multicenter, Open-Label, Dose-Escalation, Combination Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer, Who in the Opinion of Their Physician, Cannot Be Satisfactorily Treated With Surgery, Radiation or Platinum Chemotherapy
A Phase 1/2a Multicenter, Open-Label, Dose-Escalation, Combination Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer, Who in the Opinion of Their Physician, Cannot Be Satisfactorily Treated With Surgery, Radiation or Platinum Chemotherapy
Enrollment Status: Completed
Publish Date: February 26, 2020
Intervention Type: Combination product
Study Phase: Phase 1/Phase 2
View 8 Less Clinical Trials

133 Total Publications

Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial.
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 04, 2025
View All 133 Publications
Similar Doctors
Robert T. Sataloff
Distinguished in Perichondritis
Dr. Robert T. Sataloff
Otolaryngology
Distinguished in Perichondritis
Dr. Robert T. Sataloff
Otolaryngology
219 North Broad Street, Floor 10, 
Philadelphia, PA 
 (0.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Sataloff is an Otolaryngologist in Philadelphia, Pennsylvania. Dr. Sataloff is rated as a Distinguished provider by MediFind in the treatment of Perichondritis. His top areas of expertise are Spasmodic Dysphonia, Perichondritis, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Laryngectomy. Dr. Sataloff is currently accepting new patients.

Distinguished in Perichondritis
Dr. Kevin P. Leahy
Otolaryngology
Distinguished in Perichondritis
Dr. Kevin P. Leahy
Otolaryngology

University Of Penn - Medical Group

145 King Of Prussia Road G-103, Oral/maxillo Surg Radnor, 
Radnor, PA 
 (12.1 miles away)
610-902-2100
Languages Spoken:
English
See accepted insurances

Kevin Leahy is an Otolaryngologist in Radnor, Pennsylvania. Dr. Leahy is rated as a Distinguished provider by MediFind in the treatment of Perichondritis. His top areas of expertise are Laryngeal Nerve Damage, Tracheobronchomalacia, Acquired Tracheomalacia, Laryngectomy, and Gastrostomy.

Distinguished in Perichondritis
Dr. Amanda C. Hu
Otolaryngology
Distinguished in Perichondritis
Dr. Amanda C. Hu
Otolaryngology
219 N Broad St Fl 10, Philadelphia Ear Nose & Throat Associates, 
Philadelphia, PA 
 (0.2 miles away)
215-762-5530
Languages Spoken:
English
See accepted insurances

Amanda Hu is an Otolaryngologist in Philadelphia, Pennsylvania. Dr. Hu is rated as an Advanced provider by MediFind in the treatment of Perichondritis. Her top areas of expertise are Spasmodic Dysphonia, Perichondritis, Subglottic Stenosis, Laryngectomy, and Endoscopy.

VIEW MORE PERICHONDRITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cognetti's expertise for a condition
ConditionClose
  • Elite
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
    Dr. Cognetti is
    Elite
    . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
    See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
  • Laryngectomy
    Dr. Cognetti is
    Elite
    . Learn about Laryngectomy.
    See more Laryngectomy experts
  • Salivary Duct Stones
    Dr. Cognetti is
    Elite
    . Learn about Salivary Duct Stones.
    See more Salivary Duct Stones experts
  • Sialadenitis
    Dr. Cognetti is
    Elite
    . Learn about Sialadenitis.
    See more Sialadenitis experts
  • Distinguished
  • Acinic Cell Carcinoma of Salivary Glands
    Dr. Cognetti is
    Distinguished
    . Learn about Acinic Cell Carcinoma of Salivary Glands.
    See more Acinic Cell Carcinoma of Salivary Glands experts
  • Anaplastic Thyroid Cancer
    Dr. Cognetti is
    Distinguished
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
  • Gastrostomy
    Dr. Cognetti is
    Distinguished
    . Learn about Gastrostomy.
    See more Gastrostomy experts
  • Laryngeal Cancer
    Dr. Cognetti is
    Distinguished
    . Learn about Laryngeal Cancer.
    See more Laryngeal Cancer experts
  • Oral Squamous Cell Carcinoma
    Dr. Cognetti is
    Distinguished
    . Learn about Oral Squamous Cell Carcinoma.
    See more Oral Squamous Cell Carcinoma experts
  • Papillary Thyroid Cancer
    Dr. Cognetti is
    Distinguished
    . Learn about Papillary Thyroid Cancer.
    See more Papillary Thyroid Cancer experts
View All 11 Distinguished Conditions
  • Advanced
  • Adenoid Cystic Carcinoma
    Dr. Cognetti is
    Advanced
    . Learn about Adenoid Cystic Carcinoma.
    See more Adenoid Cystic Carcinoma experts
  • Aseptic and Alopecic Nodules of Scalp (AANS)
    Dr. Cognetti is
    Advanced
    . Learn about Aseptic and Alopecic Nodules of Scalp (AANS).
    See more Aseptic and Alopecic Nodules of Scalp (AANS) experts
  • Dry Mouth
    Dr. Cognetti is
    Advanced
    . Learn about Dry Mouth.
    See more Dry Mouth experts
  • Endoscopy
    Dr. Cognetti is
    Advanced
    . Learn about Endoscopy.
    See more Endoscopy experts
  • Epithelial-Myoepithelial Carcinoma
    Dr. Cognetti is
    Advanced
    . Learn about Epithelial-Myoepithelial Carcinoma.
    See more Epithelial-Myoepithelial Carcinoma experts
  • Follicular Thyroid Cancer
    Dr. Cognetti is
    Advanced
    . Learn about Follicular Thyroid Cancer.
    See more Follicular Thyroid Cancer experts
View All 17 Advanced Conditions
  • Experienced
  • Angiosarcoma of the Scalp
    Dr. Cognetti is
    Experienced
    . Learn about Angiosarcoma of the Scalp.
    See more Angiosarcoma of the Scalp experts
  • Ear Cancer
    Dr. Cognetti is
    Experienced
    . Learn about Ear Cancer.
    See more Ear Cancer experts
  • Eccrine Porocarcinoma
    Dr. Cognetti is
    Experienced
    . Learn about Eccrine Porocarcinoma.
    See more Eccrine Porocarcinoma experts
  • Ewing Sarcoma
    Dr. Cognetti is
    Experienced
    . Learn about Ewing Sarcoma.
    See more Ewing Sarcoma experts
  • Gastroesophageal Reflux Disease (GERD)
    Dr. Cognetti is
    Experienced
    . Learn about Gastroesophageal Reflux Disease (GERD).
    See more Gastroesophageal Reflux Disease (GERD) experts
  • Glossectomy
    Dr. Cognetti is
    Experienced
    . Learn about Glossectomy.
    See more Glossectomy experts
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.